Nurix Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
485
across all filing types
Latest filing
2026-05-15
Regulatory Filings
Country
US
United States of America
Listing
US
NRIX
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of medicines based on targeted protein degradation. The company's proprietary DEL-AI drug discovery engine is used to create therapies that harness the body's natural cellular machinery to eliminate disease-causing proteins. Its pipeline features multiple modalities, including small molecule degraders and Degrader Antibody Conjugates (DACs), which combine the specificity of an antibody with the catalytic potency of a degrader. These investigational therapies are being advanced for the treatment of various cancers and autoimmune diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| 10-Q - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | |
| 8-K - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | |
| SCHEDULE 13G/A - Nurix Therapeutics, Inc. (0001549595) (Subject) | 2026-03-27 | English | |
| ARS - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | |
| DEFA14A - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46361664 | 8-K | 2026-05-15 | English | ||
| 33801814 | 10-Q - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | ||
| 33801779 | 8-K - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-04-08 | English | ||
| 33062326 | SCHEDULE 13G/A - Nurix Therapeutics, Inc. (0001549595) (Subject) | 2026-03-27 | English | ||
| 33057550 | ARS - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | ||
| 33057619 | DEFA14A - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | ||
| 33057567 | DEF 14A - Nurix Therapeutics, Inc. (0001549595) (Filer) | 2026-03-27 | English | ||
| 32893678 | 4 - NURIX THERAPEUTICS, INC. (0001549595) (Filer) | 2026-03-03 | English | ||
| 30505731 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 18848146 | 4 - Nurix Therapeutics, Inc. (0001549595) (Issuer) | 2026-02-10 | English | ||
| 30505791 | 4 Filing | 2026-02-10 | English | ||
| 30505758 | 4 Filing | 2026-02-10 | English | ||
| 30505741 | 4 Filing | 2026-02-10 | English | ||
| 30505570 | 4 Filing | 2026-02-10 | English | ||
| 30505796 | 4 Filing | 2026-02-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
Nurix Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32519/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32519 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32519 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32519 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32519}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Nurix Therapeutics, Inc. (id: 32519)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.